PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35332309-8	2022	In an orthotopic mouse model of GBM, we demonstrate that the BCL-XL inhibitor A1331852 can penetrate the brain, with A1331852 detected in both tumour and healthy brain regions.	A-1331852	78-86	BCL2-like 1	Mus musculus	61-67	
33073261-5	2020	It also exhibited synergy with ibrutinib, selinexor, venetoclax and A-1331852 (a novel BCL-XL inhibitor).	A-1331852	68-77	BCL2-like 1	Mus musculus	87-93	
28802066-12	2018	Treatment with the Bcl-xL-specific inhibitor, A-1331852, reduces liver fibrosis, possibly by a dual effect on activated fibroblasts and senescent cholangiocytes.	A-1331852	46-55	BCL2-like 1	Mus musculus	19-25	
35332309-8	2022	In an orthotopic mouse model of GBM, we demonstrate that the BCL-XL inhibitor A1331852 can penetrate the brain, with A1331852 detected in both tumour and healthy brain regions.	A-1331852	117-125	BCL2-like 1	Mus musculus	61-67